Effect of branched-chain amino acids on proteolytic enzymes gene expression in rat liver

1993 ◽  
Vol 12 ◽  
pp. 36
Author(s):  
A.L. Andreu ◽  
S. Schwartz ◽  
J. López ◽  
M.A. Arbós ◽  
M. Quiles ◽  
...  
Keyword(s):  
Gene Expression ◽  
Amino Acids ◽  
Rat Liver ◽  
Proteolytic Enzymes ◽  
Branched Chain Amino Acids ◽  
Branched Chain

Branched chain amino Acids as in vitro and in vivo Anti-Oxidation Compounds

2021 ◽  
pp. 3899-3904
Author(s):  
Moath Alqaraleh ◽  
Violet Kasabri ◽  
Ibrahim Al-Majali ◽  
Nihad Al-Othman ◽  
Nihad Al-Othman ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Gene Expression ◽  
Amino Acids ◽  
Branched Chain Amino Acids ◽  
Raw 264.7 ◽  
Raw 264.7 Cell ◽  
Branched Chain ◽  
Raw 264.7 Cell Line

Background and aims: Branched chain amino acids (BCAAs) can be tightly connected to metabolism syndrome (MetS) which can be counted as a metabolic indicator in the case of insulin resistance (IR). The aim of this study was to assess the potential role of these acids under oxidative stress. Material and Methods: the in vitro antioxidant activity of BCAAs was assessed using free radical 1, 1-diphenyl-2-picryl-hydrazyl (DPPH) scavenging assays. For further check, a qRT-PCR technique was madefor detection the extent of alterations in gene expression of antioxidative enzymes (catalase and glutathione peroxidase (Gpx)) in lipopolysaccharides (LPS(-induced macrophages RAW 264.7 cell line. Additionally, BCAAs antioxidant activity was evaluated based on plasma H2O2 levels and xanthine oxidase (XO) activity in prooxidative LPS-treated mice. Results: Different concentrations of BCAAs affected on DPPH radical scavenging activity but to lesser extent than the ascorbic acid. Besides, BCAAs obviously upregulated the gene expression levels of catalases and Gpx in LPS-modulated macrophage RAW 264.7 cell line. In vivo BCAAs significantly minimized the level of plasma H2O2 as well as the activity of XO activity under oxidative stress. Conclusion: our current findings suggest that BCAAs supplementation may potentially serve as a therapeutic target for treatment of oxidative stress occurs with atherosclerosis, IR-diabetes, MetS and tumorigenesis.

scholarly journals Alteration in gene expression of branched-chain keto acid dehydrogenase kinase but not in gene expression of its substrate in the liver of clofibrate-treated rats

1996 ◽  
Vol 317 (2) ◽  
pp. 411-417 ◽  
Author(s):  
Harbhajan S. PAUL ◽  
Wei-Qun LIU ◽  
Siamak A. ADIBI
Keyword(s):  
Gene Expression ◽  
Rat Liver ◽  
Fold Increase ◽  
Branched Chain Amino Acids ◽  
The Other ◽  
Mrna Levels ◽  
Keto Acid ◽  
Protein Mass ◽  
Acid Dehydrogenase ◽  
Branched Chain

We previously showed that the oxidation of branched-chain amino acids is increased in rats treated with clofibrate [Paul and Adibi (1980) J. Clin. Invest. 65, 1285–1293]. Two subsequent studies have reported contradictory results regarding the effect of clofibrate treatment on gene expression of branched-chain keto acid dehydrogenase (BCKDH) in rat liver. Furthermore, there has been no previous study of the effect of clofibrate treatment on gene expression of BCKDH kinase, which regulates the activity of BCKDH by phosphorylation. The purpose of the present study was to investigate the above issues. Clofibrate treatment for 2 weeks resulted in (a) a 3-fold increase in the flux through BCKDH in mitochondria isolated from rat liver, and (b) a modest but significant increase in the activity of BCKDH. However, clofibrate treatment had no significant effect on the mass of E1α, E1β, and E2 subunits of BCKDH or the abundance of mRNAs encoding these subunits. On the other hand, clofibrate treatment significantly reduced the activity, the protein mass and the mRNA levels of BCKDH kinase in the liver. In contrast to the results obtained in liver, clofibrate treatment had no significant effect on any of these parameters of BCKDH kinase in the skeletal muscle. In conclusion, our results show that clofibrate treatment increases the activity of BCKDH in the liver and the mechanism of this effect is the inhibition of gene expression of the BCKDH kinase.

scholarly journals Developmental changes in rat liver branched-chain 2-oxo acid dehydrogenase

1982 ◽  
Vol 204 (2) ◽  
pp. 487-492 ◽  
Author(s):  
E E May ◽  
M E May ◽  
R P Aftring ◽  
M G Buse
Keyword(s):  
Amino Acids ◽  
Rat Liver ◽  
Maternal Diabetes ◽  
Perinatal Period ◽  
Branched Chain Amino Acids ◽  
Developmental Changes ◽  
Acid Dehydrogenase ◽  
Period 2 ◽  
Liver Homogenates ◽  
Branched Chain

Branched-chain 2-oxo acid dehydrogenase catalyses the first irreversible step in the degradation of the branched-chain amino acids leucine, isoleucine and valine. With specifically labelled 4-methyl-2-oxo[1-14C]pentanoate as substrate, the enzyme's activity was measured in rat liver homogenates. Activity (per g wet wL of liver or per mg of protein) increased most rapidly during the perinatal period (2 days before to 1 day after birth), reaching approximately adult values by the time of weaning. The apparent Vmax, of the enzyme increased with age, but its Km appeared unchanged. The data suggest that hepatic branched-chain 2-oxo acid dehydrogenase is induced or activated during the perinatal period. The enzyme's activity at birth was unaffected by maternal diabetes, or by treating the mother with pharmacological doses of corticosterone or 3,3',5-tri-iodothyronine, during the last 5 days of pregnancy.

Effect of Branched-Chain Amino Acids on Albumin Gene Expression in the Liver of Galactosamine-Treated Rats

1998 ◽  
Vol 9 (4) ◽  
pp. 209-214 ◽  
Author(s):  
Masashi Kuwahata ◽  
Tatsuzo Oka ◽  
Kozo Asagi ◽  
Hideaki Kohri ◽  
Akinobu Kato ◽  
...  
Keyword(s):  
Gene Expression ◽  
Amino Acids ◽  
Branched Chain Amino Acids ◽  
Albumin Gene ◽  
Branched Chain
Sign in / Sign up

Export Citation Format

Share Document